Lower HDL-cholesterol among healthy middle-aged Japanese-Brazilians in São Paulo compared to Natives and Japanese-Brazilians in Japan

Andiara Schwingel; Wojtek Chodzko-Zajko; Ryosuke Shigematsu; Christopher Erb; Simone Souza; Tomoaki Matsuo; Suely Marie
January 2007
European Journal of Epidemiology;Jan2007, Vol. 22 Issue 1, p33
Academic Journal
Abstract??Blood lipid levels are determined by a combination of genetic and environmental factors. Higher than average values of high-density lipoprotein cholesterol (HDL-cholesterol) have been observed in people of Japanese ethnicity. The aim of this study was to investigate whether Japanese immigrants to Brazil and subsequent generations maintain the protective benefits associated with higher levels of HDL-cholesterol, and to examine the potential associations between HDL-cholesterol and a variety of other blood lipids, anthropometric and lifestyle factors. Healthy men and women aged 35?years and older who were Native Japanese (n?=?198) or Japanese-Brazilians (JB) living in S?o Paulo, Brazil (n?=?198) and in some Japanese cities (n?=?246) were investigated. Anthropometric variables, blood lipids including HDL-cholesterol, and lifestyle factors were assessed. Serum HDL-cholesterol was observed to be lower for JB in S?o Paulo (both women and men) compared with Natives and JB in Japan. Among the groups, triglycerides, waist circumference, LDL-cholesterol, meat intake, stress, and smoking were observed to be independently negatively associated with HDL-cholesterol, whereas total cholesterol, fish intake, and physical activity were positively associated. Lower levels of HDL-cholesterol among both men and women of JB in S?o Paulo compared with both other groups were confirmed even after lifestyle adjustments. Our findings highlight the significantly lower levels of HDL-cholesterol among Japanese-Brazilians living in S?o Paulo city compared to Japanese-Brazilians and Native Japanese residing in Japan. Although several lifestyle factors were found to be significantly associated with HDL-cholesterol, they cannot adequately explain the role of the Brazilian cultural environment on HDL-cholesterol levels.


Related Articles

  • Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial. Vincent Soriano; Pilar García-Gasco; Eugenia Vispo; Andrés Ruiz-Sancho; Francisco Blanco; Luz Martín-Carbonero; Sonia Rodríguez-Novoa; Judit Morello; Carmen de Mendoza; Pablo Rivas; Pablo Barreiro; Juan González-Lahoz // Journal of Antimicrobial Chemotherapy (JAC);Jan2008, Vol. 61 Issue 1, p200 

    : Background Atazanavir seems to be a protease inhibitor (PI) with a more favourable metabolic profile. Information regarding the potential benefit of replacing lopinavir/ritonavir by atazanavir in HIV-infected patients with prolonged viral suppression is scarce. If proved, this strategy could...

  • Mitochondrial membrane cholesterol, the voltage dependent anion channel (VDAC), and the Warburg effect. Andrew Campbell; Samuel Chan // Journal of Bioenergetics & Biomembranes;Jun2008, Vol. 40 Issue 3, p193 

    Abstract  Normal cells of aerobic organisms synthesize the energy they require in the form of ATP via the process of oxidative phosphorylation. This complex system resides in the mitochondria of cells and utilizes oxygen to produce a majority of cellular ATP. However, in most tumors,...

  • HNF4α is a Crucial Modulator of the Cholesterol-Dependent Regulation of NPC1L1. Yuki Iwayanagi; Tappei Takada; Hiroshi Suzuki // Pharmaceutical Research;May2008, Vol. 25 Issue 5, p1134 

    Abstract Purpose  Niemann-Pick C1-like 1 (NPC1L1) has been identified as a target of ezetimibe and found to be responsible for intestinal cholesterol absorption. Although, it was recently demonstrated that sterol responsive element binding protein 2 (SREBP2) is responsible for...

  • Do we need lipid clinics? Shifting the balance between secondary and primary care. Stuart, W; Smellie, A // Annals of Clinical Biochemistry;Nov2005, Vol. 42 Issue 6, p463 

    Background: Increasing activity in cholesterol lowering is placing increasing demands on lipid clinics to be able to cope with the increase in demand. A combination of interventions has been used to improve laboratory testing, focus interpretative results and provide educational and advisory...

  • False negative results in the Roche assay for HDL-cholesterol. Bakker, Andries J; Zijlstra, Appie; Leemhuis, Marten P // Annals of Clinical Biochemistry;Sep2003, Vol. 40 Issue 5, p572 

    Measurement of HDL-cholesterol is important in the risk evaluation of cardiovascular disease. Recently, we encountered a 61-year-old man with a negative result for HDL-cholesterol using the Roche assay. Further analysis revealed that this patient had a monoclonal Ig type IgMκ, with an...

  • Comparison of lipid and non-lipid markers of atherosclerosis in arterial versus venous blood. Palmer, Bruce; Watson, Linley E; Riggs, Mark W; Lawrence, Mark; Baisden, Clinton E; McNeal, Catherine J; Macfarlane, Ronald D // Annals of Clinical Biochemistry;May2003, Vol. 40 Issue 3, p286 

    Background: Early studies have suggested that there may be differences in the concentration of lipoprotein particles and their associated apolipoproteins in arterial and venous blood and that this gradient might explain a proclivity to develop atherosclerotic lesions. The aim of this study was...

  • Cholesterol precursors and facial clefting. Porter, Forbes D. // Journal of Clinical Investigation;Sep2006, Vol. 116 Issue 9, p2322 

    Inborn errors of cholesterol synthesis cause human malformation syndromes, including Smith-Lemli-Opitz syndrome, lathosterolosis, desmosterolosis, X-linked dominant chondrodysplasia punctata type 2, and congenital hemidysplasia with ichthyosiform erythroderma and limb defects. Because adequate...

  • Relationship Between Components of Metabolic Syndrome and Polysomnographic Findings in Obstructive Sleep Apnea. Ozol, Duygu; Turkay, Cansel; Kasapoglu, Benan; Karamanlı, Harun; Yıldırım, Zeki // Metabolic Syndrome & Related Disorders;Feb2011, Vol. 9 Issue 1, p13 

    Aims: Obstructive sleep apnea/hypoapnea syndrome (OSAHS) and metabolic syndrome are both growing health concerns, owing to the worldwide obesity epidemic. This study evaluates the potential association between the parameters of metabolic syndrome and OSAHS. Methods: A total of 125 consecutive...

  • Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe. van Heyningen, Charles // Annals of Clinical Biochemistry;Sep2005, Vol. 42 Issue 5, p402 

    A case is presented of a patient who developed acute hepatitis during cholesterol-lowering treatment with atorvastatin and ezetimibe. Further investigations reveal a probable drug-induced autoimmune hepatitis, and ezetimibe is considered to be the most likely causal agent. This case is the first...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics